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Abstract
Objectives—To assess whether patients with heart disease in a single UK hospital have equita-
ble access to exercise testing, coronary angiography, and coronary artery bypass graft surgery
(CABG).
Method—Retrospective analysis of patients’ medical case notes (n = 1790), tracking each case
back 12 months and forward 12 months from the patient’s date of entry to the study.
Setting—Single UK district hospital in the Thames Region.
Patients—Patients (elective and emergency) with a cardiac ICD inpatient code at discharge or
death, or who were referred to cardiology or care of the elderly unit over a 12 month period in
1996–7 (new episodes) were included.
Results—Analysis of 1790 hospital case notes revealed that, despite having indications for inter-
vention identical to those of younger patients, older patients (that is, those aged > 75 years) and
women, independently, were significantly less likely to undergo exercise tolerance testing
(exercise ECG) and cardiac catheterisation. The similar trends for age and access to CABG did
not achieve significance. While clinical priority scores also independently predicted access to car-
diac catheterisation and CABG, considerable numbers of patients in high clinical priority groups
were not referred for either procedure.
Conclusions—The management and treatment of older patients and women with cardiac
disease may be diVerent from that of younger patients and men. Given the similarity of the indi-
cations for treatment and the lack of significant contraindications or comorbidities as a cause for
these diVerences, one possible explanation is that these patients are being discriminated against
principally because of their age and sex. Although clinical priority scores independently predicted
access to catheterisation and CABG, large proportions of patients in high priority groups were
not referred. This implies that the New Zealand priority scoring system may be more equitable
than UK practice. The cost implications of redressing these inequities in service provision would
be considerable.
(Heart 2001;85:680–686)
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The UK has one of the highest rates of heart
disease in the developed world but one of the
lowest surgical intervention rates (for example,
coronary artery bypass grafting (CABG)).1
Recent National Health Service (NHS) per-
formance indicators have illustrated the ineq-
uity of provision of CABG, as patients with
heart disease in some parts of England may be
up to four times more likely to obtain heart
surgery as patients in other health districts.2
Reasons for this variability are unclear.
Decisions to investigate patients invasively
and subsequent management decisions about
revascularisation involve issues of clinical
appropriateness, patients preferences, and the
personal preferences and bias of the physi-
cian.3 4 The potential for a subjective element
in clinical decision making, and consequent
scope for bias, strengthens the case for using
clinical priority scoring systems for CABG.
The system developed in New Zealand identi-
fies patients most likely to derive substantial
health benefit from CABG.5 6 Initially, it was
judged that government funding levels permit-
ted surgery to be oVered to patients scoring at
or above 35 points, which resulted in denial of
CABG to patients with a lower score unless
their disease worsens and they are regraded.
Although all clinical scoring systems inevitably
generate controversy, this system was wel-
comed by many clinicians despite concerns
about inadequate total levels of funding, the
arbitrary nature of the cut oV point below
which surgery would not be funded, and the
scope for patients and doctors to exaggerate
symptoms to achieve a higher grading.7
Recently, the National Service Framework
has set standards for prevention, diagnosis and
treatment for coronary heart disease in the
UK.8 The aim is to reduce deaths from circula-
tory diseases. To achieve this aim there must be
substantial increases in rates of revascularisa-
tion using percutaneous techniques or CABG.
To achieve this and deliver an equitable distri-
bution of health care, it is necessary to measure
the size of the gap between clinical indications
for an intervention and the financially aVord-
able level of intervention.
This study provides data on a cross section of
hospital patients in a single district general
hospital in the UK. The hospital does not have
access to either onsite angiographic facilities or
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cardiothoracic surgery. The aim of this study
was to analyse access to exercise testing, coron-
ary angiography, and CABG for patients with
diagnosed heart disease by age and sex. Indica-
tions for investigation and treatment were then
compared with internationally accepted guide-
lines including referral for CABG by the New
Zealand priority score. Target end points for
the study were whether the patient received
appropriate interventions where indicated,
based on appropriateness criteria, after taking
into consideration documented contraindica-
tions. This study was performed by retrospec-
tive external review, thus removing any poten-
tial bias among the treating clinicians (in terms
of influencing their practice by the eVects of
being studied).
Methods
The study was a case note analysis of all inpa-
tients (elective and emergency) with a cardiac
International classification of diseases, 10th revi-
sion (ICD-10) code and new cardiac outpa-
tients (new episodes) attending cardiology or
care of the elderly clinics. This wide catchment
ensured that eligible patients were not missed
and enabled equity of treatment to be explored
from a broader perspective. The participating
hospital trust was situated in the Thames area
and served a catchment population of 185 000
in a socially deprived urban area by national
standards (based on Jarman index scoring).
Analysis of national hospital inpatient statistics,
available from the Department of Health,
shows that the intervention rate for CABG in
the local population catchment area was com-
parable with the national average. The focus of
this research was on ischaemic heart disease.
Other cardiac conditions were included to
ensure that eligible patients were not missed
(for example, patients with more than one car-
diac condition).
Patients’ case notes were eligible for inclu-
sion in the study if they were admitted or first
attended (new episodes) the study hospital
during 1 April 1996 to 31 March 1997 (again,
retrospective to ensure data completeness and
no Hawthorne eVect on clinical practice).
Patients’ medical casenotes were analysed
retrospectively (n = 1790) by tracking each
case back 12 months and forward 12 months
from the patient’s date of entry to the study.
Thus, the last patient follow up date was 31
March 1998. Waiting lists for interventions
were checked throughout the study period to
ensure that study patients with the indications
for intervention, without contraindications,
and who were referred for them during the
study period were not missed. The 12 month
forward tracking period was suYcient to take
waiting list times for procedures into account
(for example, the maximum for angiography
and for CABG was 7–12 months, depending
on urgency).
Of 5479 case note numbers provided, 1790
case notes were both traced and included as
eligible for study, 185 were untraced after three
searches over 18 months, and 3504 were
screened and discarded as ineligible for inclu-
sion in the study. This was because of
overinclusivity of symptoms screened for by the
research team to avoid missing eligible pa-
tients, rather than ICD miscoding by trust ICD
coding clerks. They were judged ineligible for
inclusion after checking their notes (for exam-
ple, the notes revealed that their symptoms
were not caused by cardiac conditions but, for
example, by chronic obstructive pulmonary
disease, gastrointestinal bleeding, obstetric
related problems, or viral pneumonia).
Indications for percutaneous transluminal
coronary angioplasty (PTCA) were not ana-
lysed because it was not the policy of the trust
to provide these, nor the policy of the cardiolo-
gists on the study site to perform or cross refer
for them. This was because of their belief in a
weak evidence base in support of PTCA.
DATA COLLECTION
The data collected from hospital case notes
were specialty and patient’s date of birth, sex,
symptoms, diagnoses, results of all recorded
tests and investigations, interventions, severity
and pattern of disease, comorbidity, and
indications for and contraindications to investi-
gations or treatment. Waiting lists were
checked throughout the study to ensure that
patient referrals for investigations and proce-
dures were not missed.
Severity of condition, risk, and criteria for
intervention were measured by the following
systems: Canadian Cardiovascular Society
functional classification for angina related limi-
tation on activities9; New York Heart Associ-
ation scale10; Parsonnet 1 and 2 clinical risk
scores for heart surgery11 12 (versions with and
without the age correction (bias) were used for
comparison); De Bono clinical priority criteria
for cardiac catheterisation and PTCA13; and
the New Zealand priority scores for urgency of
CABG.5 6 The cardiologists and cardiac sur-
geons who developed and tested the New Zea-
land criteria agreed to accept a specific
numerical threshold as indicative of reasonable
levels of public service provision. The New
Zealand criteria are based on the results of
published outcome studies, with the weighting
determined by meta-analysis and regressions,
and represent the clinical factors (for example,
coronary artery obstruction) considered to be
associated with the degree of benefit obtained
from surgery. The New Zealand scores do not
correct for age and are therefore not inherently
age biased. The scores reflect clinical severity
(reduction in life expectancy without
surgery)—that is, the extent and type of vessel
disease, angina, diagnostic testing (exercise
stress test), and role functioning (25–34 points:
4–8 months’ reduction of life expectancy,
intermittent pain or breathlessness when un-
dertaking activities; 35–54 points: 8–12
months’ reduction in life expectancy, much
reduced quality of life mainly through pain on
exertion; > 55 points: 1–2 years’ reduction in
life expectancy, considerably reduced quality of
life because of chest pain, breathlessness on
almost any physical activity). Contraindica-
tions including relevant comorbidity were
taken into account.
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The American College of Cardiology/
American Heart Association (ACC/AHA) in-
dications for cardiological investigations and
interventions, appropriate for 1996–8, were
applied using subsections of the fairly restric-
tive class 1 indications only, which have general
international agreement.14–16 For example, the
table for exercise testing relates only to patients
who fulfil ACC/AHA class 1 criteria (to assess
functional capacity and prognosis of patients
with known coronary artery disease): group 1
(functional capacity assessment for selected
patients after acute myocardial infarction);
group 2 (prognostic testing for selected pa-
tients with stable angina, without contraindica-
tions). The tables presented here for cardiac
catheterisation relate only to ACC/AHA class 1
group 1 (post acute myocardial infarction) and
group 2 patients (symptomatic patients with
unstable angina not responding to medical
treatment, without contraindications). These
catheterisation patients were then analysed by
clinical priority and severity scoring in relation
to receipt of CABG. The ACC/AHA scores do
not correct for age and thus contain no inher-
ent age bias.
Reliability checks were carried out by an
independent coder on decisions to discard and
confirmed that all of the discarded cases were
ineligible. Hospital ICD coding was validated
by researchers’ ICD coding from the notes,
with good concordance at 80% (Cohen’s ê
0.667; standard error (SE) 0.05; confidence
interval (CI) 0.57 to 0.77). Intercoder reliabil-
ity was tested on a sample of 251 casenotes and
showed high levels of consistency on all
recorded data.
STATISTICAL ANALYSIS
÷2 and ÷2 trend tests were used to compare dis-
crete variables to assess their independent
influence on the dependent variables of interest
(access to cardiac catheterisation and to
CABG). Interactions between potentially pre-
dictive variables were tested using logistic
regression analyses (odds ratios). Age, sex,
severity score, and specialty were entered as the
independent variables in each model on the
grounds of theoretical significance. Each
model adjusted for indications for, and con-
traindications to, the procedures of interest
(dependent variables), and 95% CIs were used
in each. All variables were entered simultane-
ously. The goodness of fit statistic that was used
was the −2 log likelihood for the model
containing only a constant compared with the
−log 2 likelihood for the model with all
variables entered. In bivariate and multivariate
analyses, attention was drawn to diVerences
that achieved a minimum 5% level of signifi-
cance.
Results
PATIENT CHARACTERISTICS
Fifty one per cent (911) of the 1790 patients
were men and 49% (879) were women; 47%
(838) were aged under 65 years, 22% (389)
were aged 65–75, 10% (183) were 75–80 and
21% (380) were over 80 years old. Fifty two per
cent (926) entered through cardiology or care
of the elderly outpatient clinics, and 48% (864)
were elective or emergency admissions. All
were under the care of specialists in care of the
elderly, cardiology, or general medicine.
Twenty five per cent of patients (447) had a
primary diagnosis of ischaemic heart disease
(including angina). Other main diagnoses were
heart failure (31%, 546), cardiac conduction
disorder (29%, 525), chest pain unspecified
(21%, 376), and acute myocardial infarction
(7%, 131).
Table 1 shows the sample’s distributions on
the functional status, clinical risk, and severity
(priority) classification scales used. The clinical
scales took account of relevant comorbidity
and contraindications for intervention.
EXERCISE TOLERANCE TESTING (EXERCISE ECG)
AND CARDIAC CATHETERISATION (CORONARY
ANGIOGRAPHY)
While 265 patients in total underwent exercise
tolerance testing, just 26% (155) of the 596
patients who met the ACC/AHA criteria, and
for whom an exercise tolerance test was not
contraindicated, had one.
Thirty three per cent (148) of patients aged
under 75 who met the ACC/AHA criteria for
exercise tolerance testing had this test com-
pared with just 5% (7) of those aged 75 and
over (p < 0.01). Thirty two per cent (115) of
men and 17% (40) of women who fulfilled
ACC/AHA criteria had this test (p < 0.01).
Age, sex, and specialty were entered into a
logistic regression model and all achieved
significance. Table 2 shows that the odds of
Table 1 Functional and clinical severity classifications of sample
Classification % Total sample (n) % Eligible cases (n)
Canadian Cardiovascular Society
Ineligible* 65 1154 16 52
Class I 7 130 17 57
Class II 1 20 3 10
Class III 1 12 3 9
Class IV a+b 18 327 34 109
Class IVc 8 147 27 83
Total 1790 320†
New York Heart Association
Ineligible* 65 1154 16 52
Class I 7 130 17 57
Class II 1 20 3 10
Class III 1 12 3 9
Class IV 26 474 61 192
Total 1790 320
Parsonnet 1
Good (0–4%) 44 788 41 131
Fair (5–9%) 14 252 20 65
Poor (10–14%) 10 181 12 38
High (15–19%) 7 125 7 23
Extremely high (> 20%) 444 20 63
Total 25 1790 320
Parsonnet 2
Good (0–4%) 75 1345 74 236
Fair (5–9%) 21 374 21 67
Poor (10–14%) 3 53 4 13
High (15–19%) 1 18 1 4
Extremely high (> 20%) 0 0 0 0
Total 1790 320
De Bono
0–40 90 1612 62 199
40–100 10 178 38 121
Total 1790 320
New Zealand score†
<25 48 39 48 39
25–35 16 13 16 13
35–55 36 30 35 30
Total 82 82†
*Patients without coded signs of angina; †The New Zealand score relates only to 82 patients who
had no missing cardiac catheterisation data (100 had cardiac catheterisation, with 18 missing
data).
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having an exercise test were multiplied by 0.96
for each additional year of age, indicating a
decrease with older age; and the odds of a man
getting the test were 1.63 times that of a
woman. The model included cardiology and
general medicine, with care of the elderly as the
referent.
One hundred patients were referred for car-
diac catheterisation and angiography. We
analysed only patients for whom cardiac
catheterisation was indicated, without con-
traindications, including relevant comorbidity,
using ACC/AHA criteria for angiography
(n = 320). A large proportion (83% (266)) of
all these 320 patients who fulfilled the
ACC/AHA criteria did not receive cardiac
catheterisation, across all age groups. Thus,
just 17% (54) were referred for catheterisation.
There was a significant decline after age 65 in
the proportion of patients receiving cardiac
catheterisation where indicated: 26% (36) of
those aged < 65 were referred compared with
16% (14) of those aged 65–75, 8% (3) of those
aged 75–80 and 2% (1) of those aged over 80
(p < 0.01). Women were also less likely than
men to be referred for this procedure where
indicated: 25% (49):4% (5), respectively
(p < 0.001). The trends are shown in fig 1.
Logistic regression analyses were carried
out, with cardiac catheterisation or angio-
graphy as the dependent variable, and age, sex,
De Bono clinical priority score, Parsonnet 2
(without the age weighting) risk score, and
specialty of entry as the independent variables.
Age, sex, and de Bono clinical priority score
were significant, independent predictors of
cardiac catheterisation. Table 3 shows that the
odds of undergoing cardiac catheterisation
were multiplied by 0.96 for each additional
year of age, thus indicating a decrease by age.
The odds of a man undergoing a cardiac cath-
eterisation were 5.33 times the odds of a
woman undergoing the procedure. The odds of
undergoing a cardiac catheterisation were mul-
tiplied by 1.03 for each unit increase in de
Bono clinical priority score (see table 3).
CORONARY ARTERY BYPASS GRAFTING
Of the 100 patients who were referred for car-
diac catheterisation, just 24 were referred for
CABG (four cases had missing data for the
clinical priority and severity coding, thus 20 are
analysed here), and two had PTCA.
Of the cardiac catheterisation patients, 18%
(13) who were aged under 65 were referred for
CABG compared with 24% (6) of those aged
65–75 and just one of the eight patients who
were older than 75; 22% (18) of men and 11%
(2) of women were referred. There were no
diVerences with Parsonnet 1 or 2 risk scores or
specialty and referral for CABG. The likeli-
hood of receiving a CABG following catheteri-
sation was greater for patients with a New Zea-
land clinical priority score of 35–54; 18% of
those with a low score of < 25 and 15% of
those with a higher score of 25–34 had CABG
compared with 30% of those with a score of
35–54 (p < 0.05). None of the study patients
achieved a New Zealand priority score of over
50. However, these results show that the
majority of those in the high clinical priority
group (70%) were still not referred. Of the
study patients who underwent CABG, 50%
achieved a high New Zealand clinical priority
score of 35–54 (1–2 years’ reduction in life
expectancy) compared with 33% of those who
did not get CABG. However, 50% of those who
were denied CABG also met the clinical
threshold of 25 recommended by the develop-
ers of the New Zealand scale for undergoing
CABG. The row and column percentages are
shown in table 4.
Referral for CABG was entered into a logis-
tic regression model as the dependent variable,
with age, sex, New Zealand clinical priority
score, Parsonnet 2 risk score (without the age
weighting), and specialty as the dependent
variables. Table 5 shows that the odds of having
a CABG was multiplied by 1.21 for each unit
change in New Zealand clinical priority score.
The remaining variables did not achieve
Table 2 Logistic regression analysis of whether patient had exercise tolerance test if they
met ACC/AHA criteria
b* p Value Exp(b)† 95% CI
Age –0.05 < 0.01 0.96 0.98 to 1.01
Sex‡ 0.49 < 0.03 1.63 1.02 to 2.09
Specialty§ N/A < 0.03 N/A N/A
Cardiology 2.27 < 0.27 9.72 1.33 to 3.59
General medicine 1.88 < 0.07 6.58 0.45 to 1.43
n = 596. 155 of 265 patients given an exercise tolerance test met these criteria; 110 patients were
given an exercise tolerance test but did not meet the criteria.
*Logistic regression equation is 1/1+e (−b1×1 + b2×2 + b3×3...bixi); †a unit change in an inde-
pendent variable creates a change in the odds of the dependent variable occurring by a factor of
this number—a value of 1 indicates no change in the odds; ‡coded so that being a man is 1 and
being a woman is 0; §specialty referent: care of the elderly; N/A, not applicable.
Figure 1 Patients who were not given cardiac catheterisation and met the ACC/AHA
criteria (%)
100
90
80
70
60
50
40
30
20
10
0
80+75 < 8065 < 75
Age (years)
All patients
91%
74%
72%
78%
84%
97%
92%
81%
99%
98%100%
Males Females
%
Under 65
p < 0.01
Table 3 Logistic regression of predictors of cardiac catheterisation (patients were with
treated symptoms of ischaemic heart disease and met appropriateness criteria)
b* p Value Exp(b)† 95% CI
Age −0.04 < 0.01 0.96 0.93 to 0.99
Sex‡ 1.65 < 0.01 5.33 1.98 to 14.39
De Bono score 0.03 < 0.02 1.03 1.01 to 1.06
Parsonnet 2 score§ −0.02 < 0.73 0.91 0.90 to 1.17
Specialty¶ N/A < 0.89 N/A N/A
Cardiology 6.44 < 0.62 623.9 0.00 to 9×1013
General medicine 6.42 < 0.62 615.9 0.00–9×1013
n = 320; other patients with ischaemic heart disease did not meet criteria or were not coded for
relevant variables.
*Logistic regression equation is 1/1+e (−b1×1 + b2×2 + b3×3...bixi); †a unit change in an inde-
pendent variable creates a change in the odds of the dependent variable occurring by a factor of
this number—a value of 1 indicates no change in the odds; ‡coded so that being a man is 1 and
being a woman is 0; §Parsonnet 2 score without age; ¶specialty referent is care of the elderly.
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significance in the model. However, the table
shows that, while not significant, the odds of
undergoing CABG were multiplied by 0.96 for
each additional year of age (a figure compara-
ble with that for age in relation to catheterisa-
tion, which did achieve significance), suggest-
ing that the reduced sample size weakened the
power of the study.
The local trust price for CABG in 1996–7
was £5238 per patient. Thus, the cost of
providing CABG to the 21 patients with a New
Zealand score of 35 or more who did not
receive CABG would have been £109 998, and
the costs of providing CABG to the 11 patients
with a New Zealand score of 25–35 who did
not receive CABG would have been a further
£57 618.
Discussion
The analysis of more than 2000 hospital case
notes presented here revealed that, despite
indications for intervention identical to those
of younger patients, older patients and women
were, independently, less likely to undergo
exercise testing and cardiac catheterisation.
Lack of access to catheterisation inevitably
limits their access to revascularisation proce-
dures. Given the similarity of the indications
for treatment between the younger and older
men and women in this study and the lack of
significant contraindications or comorbidities
as a cause for these diVerences, it appears that
that these patients were treated diVerently
because of their age and sex. It is unknown
whether this was because of valid clinical con-
siderations that were not documented in
patients’ case notes, an age or sex bias, or sim-
ply a more cautious approach to treatment of
older people and women, perhaps reflecting
clinicians’ more limited awareness of the
evidence base for older people and older
women, who have been generally excluded
from major clinical trials.17 Reduced access to
essential diagnostic testing where indicated, by
age and sex, probably explains the lack of
significant diVerences with age and sex and
receipt of CABG among patients who had
undergone cardiac catheterisation, although
smaller sample sizes may also have been
responsible.
A major strength of the present study is in its
design: retrospective analysis of patients’ case
notes ensured that clinical practice was not
influenced by the research process, thereby
biasing and invalidating findings. However, the
weakness of the study was also this reliance on
retrospective case note analysis, with reliance
on information documented in the notes. It is
possible that relevant comorbidity and con-
traindications to tests and treatments were not
fully documented by medical staV. It is,
however, unlikely that omissions would have
increased with the age of the patient or for
women. It was unfortunately not possible to
question clinicians retrospectively about their
decisions not to intervene. The extent to which
doctors are influenced by the visual cues their
patients give them and that are unrecorded is
unknown (for example, perceived frailty). Also,
10% of the case notes were not traced, despite
three searches over 18 months. This untraced
rate is within the range reported by other
investigators and would be fairly small within
diagnostic groups. It is therefore unlikely to be
a source of significant sample bias. A final
weakness of the study is also the single site
design, with unknown external validity. It has
been documented that the chances of receiving
an intervention are greater with increased
proximity of a patient’s residence to a specialist
centre.18 The results reported here showing low
intervention and cross referral rates from a dis-
trict general hospital are consistent with this.
The intervention rates are likely to be at the
lower end of the range of average clinical prac-
tice because, as the cardiac team openly
acknowledged during the feedback of results,
they were “low interventionist” cardiologists.
The study is thus one of clinical practice in
such a centre.
In New Zealand, in theory, all of those
patients who underwent cardiac catheterisation
with a score of 35 or more would have been
placed on the waiting list for CABG. However,
in the present study, 70% of those with a high
New Zealand priority score of 35–54 did not
receive CABG, and 85% of those with a lower
New Zealand priority score of 25–34 (the
clinically preferred threshold) did not receive
CABG. This implies that the controversial pri-
ority scoring system in operation in New Zea-
land, despite criticism, is more equitable than
UK practice as represented by this site, which
is subject to individual clinician’s thresholds
and value judgements. The cost implications of
redressing the inequities in service provision
would, of course, be considerable.
Most work on clinical priority and risk scor-
ing systems has been carried out in relation to
cardiac services.6 19–21 While none of the sys-
tems developed have 100% accuracy, the New
Zealand priority scoring system for CABG is
the most developed and is considered to be the
best available, despite criticism.19 20 22 23 How-
ever, while it correlates strongly with the
Ontario urgency score, it still underweights
Table 4 New Zealand clinical priority score by receipt of CABG
Received CABG Did not receive CABG Total
Score Column (%) Row (%) n Column (%) Row (%) n % n
< 25 38 18 7 50 82 32 48 39
25–35 12 15 2 17 85 11 16 13
35–55 50 30 9 33 70 21 36 30
Total 18 64 82
No patient scored 55 or more.
Table 5 Logistic regression analysis of predictors of CABG
b* p Value Exp(b)† 95% CI
Age −0.03 < 0.83 0.97 0.91 to 1.04
Sex‡ 0.66 < 0.70 1.94 0.24 to 14.87
New Zealand score 0.20 < 0.04 1.21 1.06 to 1.41
Parsonnet 2 score§ 0.22 < 0.09 1.25 0.88 to 1.75
Specialty¶ N/A < 0.60 N/A N/A
Cardiology 1.03 < 0.79
n = 82 because cardiac catherisation data were missing for 18 patients.
*Logistic regression equation is 1/1+e (−b1×1 + b2×2 + b3×3...bixi); †a unit change in an inde-
pendent variable creates a change in the odds of the dependent variable occurring by a factor of
this number—a value of 1 indicates no change in the odds; ‡coded so that being a man is 1 and
being a woman is 0; §Parsonnet 2 score without age; ¶general medicine is referent category as there
were no cases from care of the elderly units.
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symptoms in its scoring system19. Consistency
in assessment of urgency would be a step
forward, especially given the evidence on varia-
tions between patients placed in the same wait-
ing list priority categories in the UK when
based on the subjective judgements of clini-
cians.24 Langham and colleagues25 argued that a
two stage scoring system is preferable, which
would select those who are likely to benefit
from surgical intervention and then allocate an
urgency score related to risk of immediate
adverse events.
The Royal College of Physicians has stated:
“in assessing the ability to benefit from
treatment, chronological age is less important
than other factors concerned with the biologi-
cal ageing process and the presence of
associated disease.”26 EYcacious treatments
have their greatest impact when applied to
patients at with the greatest risk.27 Although
older patients are at higher risk of acute
myocardial infarction and other cardiovascular
events, they are less likely to receive potentially
beneficial investigations. Thus, diVerences with
age of a patient result in a “care gap”—that is,
the gap between the actual and optimal
application of eVective treatments to the whole
population at risk.27 There may be a tendency
to select low risk and younger patients for
intervention rather than those at high risk who
would benefit most. Negative, and incorrect,
assumptions are often made about the quality
of life of older people28 and “ageist” attitudes
are common both across society generally29 and
in medicine, despite education.30
A growing body of research indicates that
older people are more likely to have more
severe coronary artery disease and to be treated
less vigorously and less eVectively than younger
people, to be treated medically rather than sur-
gically, to be denied access to cardiac facilities
(including admission to coronary care units
and to cardiac rehabilitation), and to be more
likely than younger people to undergo emer-
gency or urgent cardiac interventions.31–37 It has
been suggested, on the basis of such literature,
that implicit age based prioritisation policies
are operating in health care.38
Trials and follow up studies that have
included older people have reported that most
of them are likely to experience substantial
benefit from appropriate therapeutic and
surgical cardiac interventions when risk factor
comorbidity is absent.39–43 Some, however, con-
tinue to argue that surgical intervention is less
beneficial (prognostically) in older patients—a
view that is not supported by the evidence.43
While the risks of surgery (for example, stroke
or death) increase with age, early mortality and
major morbidity are still relatively low for car-
diac surgery in older patients and there is
potentially much to be gained prognostically.
For example, in a non-randomised group of
patients aged 65 years or older, the six year
survival rate following surgery was 79%
compared with a survival rate of 64% among
the control group receiving medical treatment
only.44 Among patients with triple vessel
disease, the absolute mortality reduction was
28%. Combined data from the controlled trials
in patients younger than 65 years found that
survival at five years following surgery was
89.9% compared with 84.2% in the (medical)
control group; this equated to a smaller (5.6%)
absolute reduction in mortality.45 In a study of
octogenarians undergoing cardiac surgery in
the USA, although there were increased
perioperative risks, the longer term gains were
such that at three years after surgery, the
survival of surgically treated patients at 71.2%
was almost equal to that of similarly aged US
citizens as a whole, at 73.4%.46 The literature,
then, supports the benefits of surgical revascu-
larisation for older people where indicated.47
Functional capacity and severity of premorbid
conditions are more important than age in pre-
dicting survival and morbidity of patients. Cor-
onary revascularisation can also improve the
quality of life of older people, in comparison
with medical treatments, although CABG and
angioplasty both have diVerent types of benefi-
cial eVects.48–51 The overall conclusions of the
published literature on older people, then, are
that the risks to the few are greatly outweighed
by the benefits to the many. In fact, the benefits
of CABG are greater with increased age
because the symptoms of older people are more
severe (possibly because older people often
present in an atypical manner or because diag-
nosis and referral are delayed).34 47 From the
point of view of eYciency of outcome, the case
for treatment of older people is strong—and
even stronger than that for young people in
relation to prevention of heart disease.52 On the
other hand, the benefits in terms of increased
quality of life and length of life, as well as the
impact of future life threatening morbidities
(such as cancer) on eYciency and duration of
benefit, have yet to be carefully investigated in
the much longer term (for example, beyond
five year follow up periods).
In conclusion, apparent inequities in service
provision by age are likely to have several
causes, but these are largely undocumented,
beyond speculation, and merit further investi-
gation.
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